FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare
Syndicate content

Acceleron related Press Releases

Acceleron Initiates Phase 1 Clinical Trial for ACE-031 to Treat Diseases Involving Muscle Loss

Posted October 20, 2008

Acceleron Initiates Phase 1 Clinical Trial for ACE-031 to Treat Diseases Involving Muscle Loss CAMBRIDGE, Mass.--(BUSINESS WIRE)--October 20, 2008--Acceleron Pharma, Inc., a biopharmaceutical company... Read more...

Celgene Corporation and Acceleron Pharma Initiate Phase 2 Study of ACE-011 in Patients with Multiple Myeloma

Posted October 16, 2008

Celgene Corporation and Acceleron Pharma Initiate Phase 2 Study of ACE-011 in Patients with Multiple Myeloma CAMBRIDGE, Mass.--(BUSINESS WIRE)--October 16, 2008--Celgene Corporation (NASDAQ:CELG) and... Read more...

PRESS RELEASE: Acceleron Pharma Completes $31M Series C Financing

Posted October 30, 2007

Acceleron Pharma Completes $31M Series C Financing Top venture syndicate invests to advance expanding pipeline of products that modulate tissue growth and repair Cambridge, Mass. – October 30,... Read more...

PRESS RELEASE: Acceleron Appoints John Knopf to CEO Spot

Posted September 18, 2007

Acceleron Appoints John Knopf to CEO Spot CAMBRIDGE, MA - September 18, 2007 - Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues... Read more...